Safety and Utility of Spinal Magnetic Resonance Imaging in Patients with High-Frequency Spinal Cord Stimulators: A Prospective Single-Centre Study.


Journal

Stereotactic and functional neurosurgery
ISSN: 1423-0372
Titre abrégé: Stereotact Funct Neurosurg
Pays: Switzerland
ID NLM: 8902881

Informations de publication

Date de publication:
2019
Historique:
received: 08 03 2019
accepted: 26 09 2019
pubmed: 28 10 2019
medline: 1 4 2020
entrez: 28 10 2019
Statut: ppublish

Résumé

Implanted high-frequency spinal cord stimulators at 10 kHz (HF-SCS) have recently acquired conditional approval for magnetic resonance imaging (MRI), including retrospective application to previously implanted devices. Under certain conditions, there are greater specific absorption rate (SAR) scanning restrictions compared to some conventional alternatives. This poses technical challenges to obtain diagnostic quality imaging. To describe our experience with 9 such scans, demonstrating that safe and diagnostically useful images can be obtained despite these restrictions. We report a prospective single-centre series of 9 scans within a tertiary neuroscience centre, all obtained within the required SAR limit of ≤0.4 W/kg, and describe the scanning protocol we have developed. We further illustrate this with 2 representative patient cases. The imaging studies were well tolerated without complication. In all cases, the imaging quality was sufficient for the reporting neuroradiologist to answer the clinical question posed. Despite technical challenges, MRI is feasible, safe and diagnostically useful in HF-SCS-implanted patients. We would invite other centres that implant these devices to consider the development of their own scanning protocols to avoid the morbidity and inconvenience of explantation or computed tomography myelography. To our knowledge, this is the first reported study of MRI in HF-SCS-implanted patients achieving the requisite SAR limit of ≤0.4 W/kg.

Sections du résumé

BACKGROUND
Implanted high-frequency spinal cord stimulators at 10 kHz (HF-SCS) have recently acquired conditional approval for magnetic resonance imaging (MRI), including retrospective application to previously implanted devices. Under certain conditions, there are greater specific absorption rate (SAR) scanning restrictions compared to some conventional alternatives. This poses technical challenges to obtain diagnostic quality imaging.
OBJECTIVES
To describe our experience with 9 such scans, demonstrating that safe and diagnostically useful images can be obtained despite these restrictions.
METHODS
We report a prospective single-centre series of 9 scans within a tertiary neuroscience centre, all obtained within the required SAR limit of ≤0.4 W/kg, and describe the scanning protocol we have developed. We further illustrate this with 2 representative patient cases.
RESULTS
The imaging studies were well tolerated without complication. In all cases, the imaging quality was sufficient for the reporting neuroradiologist to answer the clinical question posed.
CONCLUSION
Despite technical challenges, MRI is feasible, safe and diagnostically useful in HF-SCS-implanted patients. We would invite other centres that implant these devices to consider the development of their own scanning protocols to avoid the morbidity and inconvenience of explantation or computed tomography myelography. To our knowledge, this is the first reported study of MRI in HF-SCS-implanted patients achieving the requisite SAR limit of ≤0.4 W/kg.

Identifiants

pubmed: 31655819
pii: 000503730
doi: 10.1159/000503730
pmc: PMC6979418
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

272-277

Informations de copyright

The Author(s). Published by S. Karger AG, Basel.

Références

Acta Neurochir (Wien). 2013 Dec;155(12):2327-32
pubmed: 24078115
AJR Am J Roentgenol. 2005 Sep;185(3):768-71
pubmed: 16120932
Spine (Phila Pa 1976). 2015 May 1;40(9):E531-7
pubmed: 25646745
Anesthesiology. 2015 Oct;123(4):851-60
pubmed: 26218762
Pain Med. 2014 Oct;15(10):1815-9
pubmed: 25159732
Anesthesiology. 2007 Apr;106(4):779-86
pubmed: 17413916
Stereotact Funct Neurosurg. 2016;94(4):254-258
pubmed: 27632184
Pain Pract. 2010 Mar-Apr;10(2):103-12
pubmed: 20070547

Auteurs

James Manfield (J)

Department of Neurosurgery, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, United Kingdom, jhrmanfield@doctors.org.uk.

Richard Bartlett (R)

Department of Radiology, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, United Kingdom.

Nicholas Park (N)

Department of Neurosurgery, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH